Similar results were shown by Kusmartseva et al. [183], suggesting that SARS-CoV-2 infection of pancreatic endocrine cells, mediated by ACE2, is an improbable pathogenic event of COVID-19-related DM development. This evidence concerns the gene ACE2 and COVID-19.